:format(webp)/cdn.mskdoctors.com/storage/2026/8/WyTUgPyuRTUUHCpsWkxQLHIH1zV03yj2.jpg)
Can ChondroFiller delay joint replacement?An injectable collagen scaffold called ChondroFiller recruits the patient's own repair cells to regenerate cartilage in 30–45 minutes. Clinical trials show IKDC score improvements averaging 32.4 points — nearly double the threshold for clinically significant change — when administered in early focal cartilage damage where joint space remains.An injectable collagen scaffold called ChondroFiller recruits the patient's own repair cells to regenerate cartilage in 30–45 minutes. Clinical trials show IKDC score improvements averaging 32.4 points — nearly double the threshold for clinically significant change — when administered in early focal cartilage damage where joint space remains.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/2of3MbpwJvcJrDYn03x9VVz3ZGqDUeFf.jpg)
ChondroFiller vs hyaluronic acid for cartilage repairChondroFiller repairs focal cartilage lesions by recruiting the patient's own cells; hyaluronic acid eases broad osteoarthritis by restoring synovial fluid. These injections treat fundamentally different conditions, and selecting the wrong one offers little clinical value.ChondroFiller repairs focal cartilage lesions by recruiting the patient's own cells; hyaluronic acid eases broad osteoarthritis by restoring synovial fluid. These injections treat fundamentally different conditions, and selecting the wrong one offers little clinical value.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/766rT75vrzgAcHwc9vxAXYr5JrU3PaGe.jpg)
ChondroFiller injection versus knee replacement for focal defectsChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.ChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/avuNKQfAKHfoMbyfAZJlsUvqvncXbBev.jpg)
Choosing between ACI and MACI for cartilage repairMACI cartilage grafts show 90% fill at two years but decline to 49% by ten years; 73% become fibrocartilage rather than the hyaline cartilage needed for durability.MACI cartilage grafts show 90% fill at two years but decline to 49% by ten years; 73% become fibrocartilage rather than the hyaline cartilage needed for durability.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/U6DuSYgVOdAX9tLjZF255RtTNw5IxIIi.jpg)
OATS or MACI for mid-size knee cartilage defectsWithin the 2–4 cm² range, cartilage defects are large enough that a single plug fails to cover them, yet small enough that two repair techniques remain viable: osteochondral autograft restores cartilage and bone in one operation but creates coverage gaps, whilst matrix-induced autologous chondrocyte implantation requires two operations with laboratory…Within the 2–4 cm² range, cartilage defects are large enough that a single plug fails to cover them, yet small enough that two repair techniques remain viable: osteochondral autograft restores cartilage and bone in one operation but creates coverage gaps, whilst matrix-induced autologous chondrocyte implantation requires two operations with laboratory culture but accommodates irregular shapes without gaps.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/8Ybarca5EyikHWwPNDgHdzL8O444HHna.jpg)
AMIC vs MACI for knee cartilage repairStandalone microfracture for knee cartilage defects has less than 60% survivorship at three years; AMIC adds a collagen membrane to stabilize repair, whilst MACI uses cultured chondrocytes and shows superiority in the SUMMIT trial for lesions over 3 cm².Standalone microfracture for knee cartilage defects has less than 60% survivorship at three years; AMIC adds a collagen membrane to stabilize repair, whilst MACI uses cultured chondrocytes and shows superiority in the SUMMIT trial for lesions over 3 cm².
:format(webp)/cdn.mskdoctors.com/storage/2026/7/8ilKw2XCH5pB5TWOt6kewJNVnwz4zE0V.jpg)
What the ChondroFiller evidence actually showsChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.ChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/ETKg1ueF5BBKIau7DxGIoPsVzI5r2krh.jpg)
ChondroFiller and Arthrosamid serve different knee conditionsChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.ChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/jsvrgfCOH4IBtCsmXXnshr2LWJGubdnf.jpg)
MACI versus microfracture for knee cartilage repairMACI outperforms microfracture for knee cartilage defects of 3 cm² or larger, according to the SUMMIT randomised trial, which found significantly greater improvements in pain and function at two years that persisted through five years.MACI outperforms microfracture for knee cartilage defects of 3 cm² or larger, according to the SUMMIT randomised trial, which found significantly greater improvements in pain and function at two years that persisted through five years.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/UY0InSBaoOinSJHR9T3qmZrV7DMIQOXA.jpg)
ChondroFiller vs PRP for focal cartilage defectsFocal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlying…Focal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlying problem.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/nJpuPYmYxVIJuCuke5TmcJtXlcYJxImS.jpg)
ChondroFiller or Arthrosamid for your kneeChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.ChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/KjpMHrbjL20lkYbuDX3KR2dJ4SZiKdyx.jpg)
MACI vs Microfracture for Knee Cartilage RepairFor focal knee cartilage defects above 3 cm², MACI outperformed microfracture across all clinical measures: pain scores improved to 82.5 versus 70.9 at two years, with durability sustained at five-year follow-up.For focal knee cartilage defects above 3 cm², MACI outperformed microfracture across all clinical measures: pain scores improved to 82.5 versus 70.9 at two years, with durability sustained at five-year follow-up.
